Mark Guttman
Western University(CA)Dalhousie University(CA)University of British Columbia(CA)University of Alberta(CA)University of Calgary(CA)University of Toronto(CA)McGill University(CA)McMaster University(CA)
Publications by Year
Research Areas
Neurological disorders and treatments, Parkinson's Disease Mechanisms and Treatments, Genetic Neurodegenerative Diseases, Mitochondrial Function and Pathology, Neurotransmitter Receptor Influence on Behavior
Most-Cited Works
- → Detection of Huntington's disease decades before diagnosis: the Predict-HD study(2007)807 cited
- → Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease(2007)377 cited
- → The role of radiotracer imaging in Parkinson disease(2005)372 cited
- → Levodopa in the treatment of Parkinson's disease: Current controversies(2004)366 cited
- → Adenosine A 2A receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002‐US‐005)(2008)347 cited
- → Identification of motor and nonmotor wearing‐off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment(2005)238 cited